DWM Going on a vegan diet accelerates weight loss and reduces harmful belly fat, new research suggests.
########################
-- Plato
3 SHOCKS TILL 30C
ADR GIVEN 8 MINLY TILL 30C
Resuscitation drugs
Drugs are often ineffective and will undergo reduced metabolism; so these are withheld below 30 C then given with twice the time interval between doses until either normothermia is approached (35 C) or circulation restored. So, adrenaline would be given about every 8-10 minutes once the core temperature is above 30 C.
Correlation of Core Temperature and Physiological Changes | |||
Grade | C | Physiological Changes | |
Mild | 35 | Maximum shivering, impaired judgment, confusion | |
34 | Tachycardia, tachypnoea, increased SVR, cold diuresis | ||
33 | Bradycardia, respiratory depression, hyperglycaemia, dysarthria, ataxia | ||
Moderate | 32 | Stupor, lethargy, arrest of shivering thermogenesis | |
31 | Atrial arrhythmia, Osborn J-waves on ECG, worsening bradycardia | ||
30 | Insulin ineffective, decreased oxygen consumption | ||
29 | Progressive decreased level of consciousness, pulse, respiratory rate | ||
Severe | 28 | Increased susceptibility for ventricular fibrillation, pulse rate and oxygen consumption decreased by 50% | |
27 | Loss of reflexes and voluntary movement, hypoglycaemia | ||
26 | Acid-base disturbances, no response to pain | ||
25 | Cerebral blood flow decreased by 2/3, pulmonary oedema, apnoea | ||
24 | Hypotension | ||
23 | Corneal and oculocephalic reflexes absent | ||
22 | Maximum risk for ventricular fibrillation, oxygen consumption 25% of normal | ||
Profound | 20 | Lowest resumption of cardiac activity, pulse 20% of normal | |
19 | Asystole |
Resuscitation drugs
Drugs are often ineffective and will undergo reduced metabolism; so these are withheld below 30 C then given with twice the time interval between doses until either normothermia is approached (35 C) or circulation restored. So, adrenaline would be given about every 8-10 minutes once the core temperature is above 30 C.
Hypomimia in Parkinson's Disease
Abstract
This abstract is available on the publisher's site.
Access this abstract nowBACKGROUND AND PURPOSE
Hypomimia is a prominent clinical feature in people with Parkinson's disease (PD), but it remains under-investigated. We aimed to examine the clinical correlates of hypomimia in PD and to determine whether this is a levodopa-responsive sign.
METHODS
We included 89 people with PD. Hypomimia was assessed from digital video recordings by movement disorder specialists. Clinical evaluation included use of the Unified Parkinson's Disease Rating Scale part III (UPDRS-III), and assessment of motor and non-motor symptoms using standardized clinical scales. The relationships between hypomimia and other clinical data were analysed using Mann-Whitney U-tests and regression analysis.
RESULTS
Hypomimia occurred in up to 70% of patients with PD. Patients with hypomimia had worse UPDRS-III 'off-medication' scores, mainly driven by bradykinesia and rigidity subscores. Patients with hypomimia also had worse apathy than patients without hypomimia. Finally, we found that hypomimia was levodopa-responsive and its improvement mirrored the change by levodopa in axial motor symptoms.
CONCLUSION
Our study provides novel information regarding the clinical correlates of hypomimia in people with PD. A better understanding of hypomimia may be relevant for improving treatment and quality of life in PD.
###############################
Hypomimia in Parkinson's Disease
Abstract
This abstract is available on the publisher's site.
Access this abstract nowBACKGROUND AND PURPOSE
Hypomimia is a prominent clinical feature in people with Parkinson's disease (PD), but it remains under-investigated. We aimed to examine the clinical correlates of hypomimia in PD and to determine whether this is a levodopa-responsive sign.
METHODS
We included 89 people with PD. Hypomimia was assessed from digital video recordings by movement disorder specialists. Clinical evaluation included use of the Unified Parkinson's Disease Rating Scale part III (UPDRS-III), and assessment of motor and non-motor symptoms using standardized clinical scales. The relationships between hypomimia and other clinical data were analysed using Mann-Whitney U-tests and regression analysis.
RESULTS
Hypomimia occurred in up to 70% of patients with PD. Patients with hypomimia had worse UPDRS-III 'off-medication' scores, mainly driven by bradykinesia and rigidity subscores. Patients with hypomimia also had worse apathy than patients without hypomimia. Finally, we found that hypomimia was levodopa-responsive and its improvement mirrored the change by levodopa in axial motor symptoms.
CONCLUSION
Our study provides novel information regarding the clinical correlates of hypomimia in people with PD. A better understanding of hypomimia may be relevant for improving treatment and quality of life in PD.
and others?” And after any action, “Is what I just did for the benefit of myself and others?”
—Sylvia Boorstein, “Dear Abbey Dharma Fall 2011”
No comments:
Post a Comment